Anthropic is facing a new US copyright lawsuit from major music publishers alleging the company used thousands of protected songs without permission to train itsAnthropic is facing a new US copyright lawsuit from major music publishers alleging the company used thousands of protected songs without permission to train its

Anthropic Faces $3B Copyright Lawsuit From Major Music Publishers Over AI Training Practices

2026/01/30 21:29
3 min read
Anthropic Faces $3B Copyright Lawsuit From Major Music Publishers Over AI Training Practices

AI research company Anthropic is facing a new copyright lawsuit filed on Wednesday in the US District Court for the Northern District of California by a group of major music publishers, including Universal Music Group, Concord and ABKCO. The complaint alleges that the company improperly used copyrighted musical works to train its Claude chatbot without authorization.

According to the publishers, Anthropic unlawfully reproduced and incorporated more than 700 individual compositions, including song lyrics and sheet music for titles such as “Wild Horses” by the Rolling Stones, Neil Diamond’s “Sweet Caroline,” and Elton John’s “Bennie and the Jets.” The filing further claims that the company’s use of protected material extends beyond those examples and affects thousands of additional works owned or administered by the plaintiffs.

In a public statement accompanying the filing, the publishers said they are pursuing infringement claims covering more than 20,000 songs in total and are seeking statutory damages that could exceed $3 billion. They described the action as potentially one of the largest non-class action copyright cases ever brought in the United States.

The lawsuit states that collections of allegedly pirated books used in the training process contained copyrighted sheet music and lyrics associated with at least 714 songs controlled by the publishers. The plaintiffs argue that the reproduction and use of these materials violated their exclusive rights under U.S. copyright law.

The case has been filed under the title Concord Music Group Inc. v. Anthropic PBC, No. 3:26-cv-00880, in the US District Court for the Northern District of California. Legal representation for the publishers includes attorneys from Oppenheim + Zebrak, Coblentz Patch Duffy & Bass, and Cowan, Liebowitz & Latman.

This newly filed lawsuit follows and expands upon a separate case initiated by the same group of music publishers against Anthropic in 2023, which also centered on allegations that the company used their copyrighted material to train its Claude large language model to generate responses to user prompts. Anthropic has publicly rejected the claims made in both actions and maintains that its training practices comply with applicable law.

The dispute emerges against the backdrop of a major legal development involving Anthropic last year, when the company reached a $1.5 billion settlement in a separate copyright case brought by a group of book authors. In that matter, US District Judge William Alsup concluded that the doctrine of fair use protected Anthropic from infringement liability arising specifically from the use of copyrighted books for artificial intelligence training. At the same time, the court indicated that the company could nonetheless face separate exposure for the alleged unauthorized copying of the underlying books themselves, noting that such conduct could, in theory, give rise to damages reaching as high as $1 trillion.

The growing body of litigation reflects a broader legal and regulatory confrontation between creators and artificial intelligence developers. Across the technology sector, major AI companies are increasingly being targeted by copyright holders, including writers, music publishers, and visual artists, who claim that their works were used without permission to train generative models. In response, many technology firms have consistently argued that the ingestion of copyrighted material for training purposes falls within the scope of fair use under US copyright law, setting the stage for a series of landmark court decisions that are expected to shape the future of AI development and intellectual property rights.

The post Anthropic Faces $3B Copyright Lawsuit From Major Music Publishers Over AI Training Practices appeared first on Metaverse Post.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26